Orient Cement Limited
Valuation (91/100) does the heavy lifting; momentum (30/100) is the drag.
Buy zoneOur blended model reads Orient Cement Limited as a Buy at 64/100. At ₹136.64 it trades below our blended DCF and relative-multiples fair value of ₹273.28, about 100% upside to that estimate — we read it as undervalued by 100%. On 8.3x trailing earnings it sits cheaper than the Basic Materials median of about 22.2x. The price is about 45% below its 52-week high of ₹246.33 and 12% above the low of ₹122.42. Financial health scores 61/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 1/9. The average analyst target of ₹188 implies about 38% upside across 2 analysts. It clears 9 of 13 investability checks, with durability 67, valuation 82 and momentum 30 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹218.62. Low-confidence estimate — limited data.
Analyst views
1-year price
EOD · 2026-07-3152-week range
-44.53% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Buy64Piotroski F-score 1/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Pass: ROE above 15%: 17.1%
- Pass: Low debt (D/E < 0.5): 0.03x
- Fail: Positive free cash flow
- Fail: Revenue growth > 10%: -22%
- Pass: Earnings growing: 32%
- Pass: Net margin ≥ 10%: 12.1%
- Pass: Current ratio > 1.5: 1.95
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 3.45
- Fail: Piotroski ≥ 7: 1/9
Quarterly results
Annual financials
Shareholding
- Promoter74.8%
- Institutions2.2%
- Public & other23.0%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
- Financially solid — Altman Z 3.45.
Opportunities
- Earnings growing (32% YoY).
- Trading in our value buy zone versus sector peers.
- Well off its 52-week high — possible mean-reversion.
- Trades ~100% below our estimated fair value.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
- Weak Piotroski score (1/9).
About Orient Cement Limited
Orient Cement Limited manufactures and sells cement products in India under the Birla A1 brand portfolio, which includes Premium Cement, StrongCrete, OrientGreen, and Dolphin variants. The company produces pozzolana and ordinary Portland cement for use in residential, commercial, infrastructure, industrial, and community projects.
Orient Cement Limited — frequently asked questions
Is Orient Cement Limited a buy, hold or sell?
StocksWizard currently rates Orient Cement Limited (ORIENTCEM) a Buy, based on a blended score of 64/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Orient Cement Limited's fair value?
Our blended DCF and relative-valuation model estimates Orient Cement Limited's fair value at about ₹273.28, versus a current price of ₹136.64 — roughly 100% upside. On that basis the stock looks undervalued by 100%.
Is Orient Cement Limited financially healthy?
Orient Cement Limited scores 61/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 1/9.
How has Orient Cement Limited's share price performed?
Orient Cement Limited is down 2% over three months, and last traded at ₹136.64. Past performance doesn't predict future returns.
More in Basic Materials
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.